A Study to Determine the Safety and Tolerability of Escalating Doses of INS365 Ophthalmic Solution

Phase 2 Completed 62 enrolled Merck Sharp & Dohme LLC

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the safety and tolerability of INS365 Ophthalmic Solution when applied topically as eyedrops in patients with mild to moderate dry eye disease.

Timeline

Start: 1999-09
Primary completion: 2000-05
Completion: 2000-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Diquafosol	Oligonucleotide (other)	—	Topical

A Study to Determine the Safety and Tolerability of Escalating Doses of INS365 Ophthalmic Solution

Summary

Timeline

Drugs

Indications